Furthermore, in CCl4-induced liver fibrosis, changes in PCPE-1 plasma concentrations revealed both progression and regression of liver fibrosis, thus highlighting the potential of PCPE-1 as a new non-invasive biomarker for diagnosing and monitoring fibrosis. The gene discussed is PCOLCE; the disease is Hepatic fibrosis.